Home › NCT06719180
Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
RecruitingPhase 4
A Prospective Randomized Controlled Trial of Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Patients 18 years and older requiring total laparoscopic hysterectomy with or without bilateral salpingo-oophorectomy for benign conditions * Presence of malignancy Exclusion Criteria: * Conversion to laparotomy * Previous multiple abdominal and/or pelvic surgeries * Significant medical comorbidities or cardiac history * Poor initial Aldrete score4 (\<10) * Significant pre-op pain medication use * Contraindication to any medication that would be used in the study (Bupivacaine, epinephrine, tramadol or oxycodone)
About the study
The purpose of this study is to determine whether an injection of a local anesthetic (Bupivacaine with epinephrine) in the vaginal cuff prior to closure would result in less immediate postoperative pain medication and increase patient comfort/satisfaction.
What is being tested
- Bupivacain (drug)
- Saline (NaCl 0,9 %) (placebo) (other)
Sponsor: MediSys Health Network · Participants: 100 · Started: Dec 1, 2024
Contact the study team
- Hosam Hanna, MD · Phone: (718) 670-5571
Official record on ClinicalTrials.gov — NCT06719180
Locations in the U.S.
| New York | Flushing Hospital Medical Center, Flushing |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.